India's DMPLOI - Jobs & Networking App
Intas Pharmaceuticals, through its subsidiary Accord Plasma B.V., has taken a significant step in its global plasma journey by entering into an agreement to acquire 100% of Prothya Biosolutions Belgium BV and its subsidiaries.
Prothya Biosolutions, with more than 60 years of expertise, operates as a leading Plasma-Derived Medicinal Products (PDMP) business. The company employs over 1,200 professionals and has a strong operational presence across Belgium, the Netherlands, and Hungary.
This strategic acquisition will strengthen Intas’s global PDMP platform, aligning with its mission of “plasma fractionation for life.” By integrating Prothya’s established capabilities, Intas aims to expand its international reach and accelerate access to plasma-derived therapies worldwide.
